Delivery Order SPE2DB22D3016-SPE2DB24FAQL0

Award Date 3/19/24
Potential Completion Date 3/20/24
Potential Value $5.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, through its Corporate Office division, to supply Nurtec ODT 75 mg tablets. The award has a ceiling value of $12,491.05 and a period of performance through March 14, 2024. AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation, serves as the prime contractor for this delivery order, which is...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The order is for Nurtec ODT 75 mg tablets and has a potential value of $1,894.84. The order does not have a set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company Amerisourcebergen Corporation. The award, valued at $40,249.65, is for the supply of the medication Nurtec ODT 75 mg tablets. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical and medical supplies to U.S. government agencies,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $4,687.76 firm-fixed-price contract is for the supply of Nurtec ODT 75 mg tablets. The award has an ultimate completion date of October 7, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds multiple Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies to provide a wide range of pharmaceutical and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Nurtec ODT 75 mg tablets. The $16,608.61 firm-fixed-price contract has an ultimate completion date of July 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these prescription medications to support military treatment facilities and other federal healthcare programs. This award is associated with AmerisourceBergen's Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Nurtec ODT 75 mg tablets. The contract has a firm fixed price of $4,071.41 and a completion date of October 11, 2024. This contract is not set aside for any special designation. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which serves as a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company headquartered in Conshohocken, Pennsylvania. The contract, valued at $14,785.97, is for the delivery of Nurtec ODT 75 mg tablets. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $23,288.14 award is for the delivery of Nurtec ODT 75 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product Nurtec ODT 75 mg tablets, with a ceiling value of $23,782.13 and a period of performance through April 16, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,977.59 firm fixed-price contract is for the supply of Nurtec ODT 75 mg tablets and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FAQL0
    Delivery Order

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product Nurtec ODT 75 mg tablets. The award, valued at $5,209.50, has a period of performance through March 20, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical with a potential value of up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. This delivery order was not set aside for any specific business category.

Generated 6/18/24, 3:33 PM